CA Stock MarketDetailed Quotes

CTX Crescita Therapeutics Inc

Watchlist
  • 0.510
  • 0.0000.00%
15min DelayMarket Closed Jul 4 16:00 ET
9.91MMarket Cap-4250P/E (TTM)

Crescita Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
341.27%456K
110.77%80K
Net income from continuing operations
-129.30%-626K
-330.39%-1.99M
-112.73%-150K
-757.44%-1.28M
-659.46%-281K
42.41%-273K
178.01%862K
24.92%1.18M
121.67%195K
94.80%-37K
Operating gains losses
80.00%9K
-96.59%6K
-80.39%10K
-1,000.00%-9K
----
-58.33%5K
2,300.00%176K
--51K
--1K
--112K
Depreciation and amortization
2.67%385K
2.38%1.51M
0.53%379K
5.31%377K
1.35%375K
2.46%375K
6.67%1.47M
8.65%377K
2.29%358K
5.41%370K
Asset impairment expenditure
62.79%70K
-16.73%438K
-12.71%158K
-36.47%108K
12.17%129K
-28.33%43K
19.55%526K
13.13%181K
6.25%170K
91.67%115K
Remuneration paid in stock
-4.55%21K
-62.90%82K
-143.75%-21K
-23.81%16K
-14.47%65K
-71.05%22K
-18.75%221K
-60.98%48K
-46.15%21K
33.33%76K
Deferred tax
--0
199.56%456K
143.01%197K
--0
--93K
--166K
-577.08%-458K
---458K
--0
--0
Other non cashItems
-276.60%-177K
68.93%-32K
124.32%45K
-466.67%-51K
310.00%21K
-146.53%-47K
-239.19%-103K
-372.06%-185K
85.71%-9K
41.18%-10K
Change In working capital
-62.17%696K
143.23%1.61M
74.20%-879K
445.00%966K
41.21%-321K
255.21%1.84M
-35.34%-3.72M
-55.00%-3.41M
-224.44%-280K
-13.28%-546K
-Change in receivables
-131.30%-601K
245.04%3.54M
88.57%-274K
2,822.00%1.36M
547.06%532K
1,423.81%1.92M
-16.41%-2.44M
-1.74%-2.4M
-111.85%-50K
-119.60%-119K
-Change in inventory
568.46%996K
48.48%-917K
52.87%-394K
-195.59%-671K
98.94%-1K
123.92%149K
-29.45%-1.78M
-416.67%-836K
78.21%-227K
79.65%-94K
-Change in payables and accrued expense
216.00%348K
-654.74%-1.29M
-50.55%-408K
1,866.67%424K
-177.84%-1M
-133.78%-300K
-76.64%232K
-179.38%-271K
-102.59%-24K
-49.17%-361K
-Change in other current assets
-166.20%-47K
-0.73%271K
103.09%197K
-804.76%-148K
439.29%151K
-44.09%71K
202.25%273K
1,177.78%97K
125.30%21K
107.27%28K
Cash from discontinued investing activities
Operating cash flow
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
341.27%456K
110.77%80K
Investing cash flow
Cash flow from continuing investing activities
0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
0
0
65.72%-290K
66.67%-74K
99.66%-2K
-333.33%-169K
Net PPE purchase and sale
--0
41.92%-133K
-707.69%-105K
-1,300.00%-28K
--0
--0
33.82%-229K
94.14%-13K
97.53%-2K
-333.33%-169K
Net business purchase and sale
----
--0
----
----
----
----
---61K
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
--0
--0
65.72%-290K
66.67%-74K
99.66%-2K
-333.33%-169K
Financing cash flow
Cash flow from continuing financing activities
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
-161.54%-272K
-1,345.12%-1.19M
Net issuance payments of debt
-9.09%-108K
70.28%-408K
-6.06%-105K
-11.96%-103K
90.74%-101K
-8.79%-99K
-293.41%-1.37M
-11.24%-99K
-12.20%-92K
-1,230.49%-1.09M
Net common stock issuance
---78K
8.39%-393K
-112.50%-153K
-33.33%-240K
--0
--0
-324.75%-429K
-30.91%-72K
-718.18%-180K
---100K
Proceeds from stock option exercised by employees
----
216.67%19K
--0
--19K
--0
----
--6K
--0
--0
--6K
Net other financing activities
---50K
----
----
----
----
----
0.00%-50K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
-161.54%-272K
-1,345.12%-1.19M
Net cash flow
Beginning cash position
13.92%9.39M
-27.30%8.24M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-20.66%11.33M
-12.24%10.74M
-19.73%10.5M
-15.79%11.74M
Current changes in cash
-93.01%142K
136.79%1.16M
75.14%-624K
-224.73%-227K
98.43%-20K
355.61%2.03M
-7.24%-3.16M
-183.62%-2.51M
120.82%182K
-47.45%-1.27M
Effect of exchange rate changes
-20.00%4K
-122.22%-14K
-220.00%-12K
-59.26%22K
-185.29%-29K
114.29%5K
1,000.00%63K
150.00%10K
100.00%54K
1,033.33%34K
End cash Position
-7.24%9.53M
13.92%9.39M
13.92%9.39M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-27.30%8.24M
-12.24%10.74M
-19.73%10.5M
Free cash from
-82.26%378K
255.56%1.94M
83.57%-366K
-78.63%97K
191.01%81K
247.07%2.13M
35.72%-1.25M
-222.43%-2.23M
268.15%454K
88.62%-89K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M341.27%456K110.77%80K
Net income from continuing operations -129.30%-626K-330.39%-1.99M-112.73%-150K-757.44%-1.28M-659.46%-281K42.41%-273K178.01%862K24.92%1.18M121.67%195K94.80%-37K
Operating gains losses 80.00%9K-96.59%6K-80.39%10K-1,000.00%-9K-----58.33%5K2,300.00%176K--51K--1K--112K
Depreciation and amortization 2.67%385K2.38%1.51M0.53%379K5.31%377K1.35%375K2.46%375K6.67%1.47M8.65%377K2.29%358K5.41%370K
Asset impairment expenditure 62.79%70K-16.73%438K-12.71%158K-36.47%108K12.17%129K-28.33%43K19.55%526K13.13%181K6.25%170K91.67%115K
Remuneration paid in stock -4.55%21K-62.90%82K-143.75%-21K-23.81%16K-14.47%65K-71.05%22K-18.75%221K-60.98%48K-46.15%21K33.33%76K
Deferred tax --0199.56%456K143.01%197K--0--93K--166K-577.08%-458K---458K--0--0
Other non cashItems -276.60%-177K68.93%-32K124.32%45K-466.67%-51K310.00%21K-146.53%-47K-239.19%-103K-372.06%-185K85.71%-9K41.18%-10K
Change In working capital -62.17%696K143.23%1.61M74.20%-879K445.00%966K41.21%-321K255.21%1.84M-35.34%-3.72M-55.00%-3.41M-224.44%-280K-13.28%-546K
-Change in receivables -131.30%-601K245.04%3.54M88.57%-274K2,822.00%1.36M547.06%532K1,423.81%1.92M-16.41%-2.44M-1.74%-2.4M-111.85%-50K-119.60%-119K
-Change in inventory 568.46%996K48.48%-917K52.87%-394K-195.59%-671K98.94%-1K123.92%149K-29.45%-1.78M-416.67%-836K78.21%-227K79.65%-94K
-Change in payables and accrued expense 216.00%348K-654.74%-1.29M-50.55%-408K1,866.67%424K-177.84%-1M-133.78%-300K-76.64%232K-179.38%-271K-102.59%-24K-49.17%-361K
-Change in other current assets -166.20%-47K-0.73%271K103.09%197K-804.76%-148K439.29%151K-44.09%71K202.25%273K1,177.78%97K125.30%21K107.27%28K
Cash from discontinued investing activities
Operating cash flow -82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M341.27%456K110.77%80K
Investing cash flow
Cash flow from continuing investing activities 054.14%-133K-41.89%-105K-1,300.00%-28K0065.72%-290K66.67%-74K99.66%-2K-333.33%-169K
Net PPE purchase and sale --041.92%-133K-707.69%-105K-1,300.00%-28K--0--033.82%-229K94.14%-13K97.53%-2K-333.33%-169K
Net business purchase and sale ------0-------------------61K------------
Cash from discontinued investing activities
Investing cash flow --054.14%-133K-41.89%-105K-1,300.00%-28K--0--065.72%-290K66.67%-74K99.66%-2K-333.33%-169K
Financing cash flow
Cash flow from continuing financing activities -138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K-161.54%-272K-1,345.12%-1.19M
Net issuance payments of debt -9.09%-108K70.28%-408K-6.06%-105K-11.96%-103K90.74%-101K-8.79%-99K-293.41%-1.37M-11.24%-99K-12.20%-92K-1,230.49%-1.09M
Net common stock issuance ---78K8.39%-393K-112.50%-153K-33.33%-240K--0--0-324.75%-429K-30.91%-72K-718.18%-180K---100K
Proceeds from stock option exercised by employees ----216.67%19K--0--19K--0------6K--0--0--6K
Net other financing activities ---50K--------------------0.00%-50K------------
Cash from discontinued financing activities
Financing cash flow -138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K-161.54%-272K-1,345.12%-1.19M
Net cash flow
Beginning cash position 13.92%9.39M-27.30%8.24M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-20.66%11.33M-12.24%10.74M-19.73%10.5M-15.79%11.74M
Current changes in cash -93.01%142K136.79%1.16M75.14%-624K-224.73%-227K98.43%-20K355.61%2.03M-7.24%-3.16M-183.62%-2.51M120.82%182K-47.45%-1.27M
Effect of exchange rate changes -20.00%4K-122.22%-14K-220.00%-12K-59.26%22K-185.29%-29K114.29%5K1,000.00%63K150.00%10K100.00%54K1,033.33%34K
End cash Position -7.24%9.53M13.92%9.39M13.92%9.39M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-27.30%8.24M-12.24%10.74M-19.73%10.5M
Free cash from -82.26%378K255.56%1.94M83.57%-366K-78.63%97K191.01%81K247.07%2.13M35.72%-1.25M-222.43%-2.23M268.15%454K88.62%-89K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg